We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

New Draft Guidance Outlines FDA’s Key Considerations for Adaptive Designs in Clinical Studies

22 May 2015

Medical Device Alert

On May 18, 2015, the Food and Drug Administration (FDA) released a draft guidance document, Adaptive Designs for Medical Device Clinical Studies, discussing considerations related to the design and implementation of adaptive designs in medical device clinical studies used to support Premarket Approval Applications (PMA), premarket notification (510(k)) submissions, de novo submissions, Humanitarian Device Exemption (HDE) applications, and Investigational Device Exemption (IDE) submissions.

Read more: New Draft Guidance Outlines FDA’s Key Considerations for Adaptive Designs in Clinical Studies

The team

Loading data